It is widely accepted the concept that tissue morphogenesis is mediated by reciprocal interactions between epithelial and mesenchymal cells, whereas the molecular details of these interactions remain largely elusive. The hair follicle (HF) is a mini-organ whose proper morphogenesis is governed by a series of interactions between epidermal and dermal cells. Due to its relatively simple structure, the HF affords an excellent model to decipher the molecular mechanisms of epithelial -mesenchymal interactions. To explore the molecular mechanisms by which Dermal Papilla (DP) cells regulate hair follicle formation, we performed a comparative transcriptome analysis and identified numerous genes preferentially expressed in the DP cells. Among these, a gene encoding type XIX Collagen (Col19a1) has become the focus of our attention because of its extensive evolutionary conservation. We generated
INTRODUCTION
Reciprocal interactions between epithelium and mesenchyme are common features of early stages of morphogenesis in different tissues and organs (Ribatti and Santoiemma, 2014) . Embryonic hair follicle induction and formation are orchestrated by mesenchymal-epithelial interactions between specialized mesenchymal dermal (DP) cells and epidermal stem cells that switch to a hair fate (Sennett and Rendl, 2012) . The Extracellular Matrix (ECM) consists of a highly heterogeneous mixture of interacting proteins that form a complex array of supra molecular structures, and that bind cell surface receptors and soluble signaling molecules (Ramirez and Rifkin, 2003) . The collagens represent the largest family of structural ECM components with 27 designated trimers that are broadly divided into fibrillar and non-fibrillar collagen types (Myllyharju and Kivirikko, 2004) . By our previous comparative transcriptome profiling using Hes5-EGFP transgenic mice, we identified genes which are preferentially expressed in DP cells.
Among these genes, α1 Collagen XIX (Col19a1) which is specifically expressed in DP cells. Collagen XIX (Col19) is a poorly characterized member of the fibrilassociated collagens with an interrupted triple helices (FACIT) class of collagen molecules. The Col19a1 gene maps to the q12-q14 region of human chromosome 6, the same region as the gene coding for the Col9a1 while the mouse Col19a1 gene is located in region A3 of chromosome 1, where the mouse Col9a1 gene has also been mapped. Taken together, this suggests that Col19a1 and Col9a1 were duplicated from the same ancestor gene of the FACIT family (Khaleduzzaman et al., 1997) .
Col19a1 is an evolutionary conserved gene from Caenorhabditis elegans (C. elegans) to human. It is localized in the circumferential annular rings and the lateral trilaminar alae of the cuticle playing a fundamental role in C. elegans exoskeleton or cuticle morphogenesis (Thein et al., 2003) . Type XIX collagen transcripts have been detected at very low levels in mouse embryonic tissues by the RT-PCR technique and in human rhabdomyosarcoma cell lines by Northern analysis (Myers et al., 1994; Sumiyoshi et al., 1997) . Col19a1 expression during embryogenesis commences at~E9.5 in the myotome and with a pattern that closely follows the myogenic regulatory factor myf-5. Transient expression of Col19a1 in muscular tissues is confined to few sites of the developing embryo, such as limbs, tongue, and the smooth muscle layers of the stomach and esophagus. Additional nonmuscular sites of Col19a1 activity include the skin of the E16.5 embryos and the cerebral cortex and hippocampus of the new born brain (Sumiyoshi et al., 2001) . Col19 is deposited at extremely low amounts in the basement membrane zones (BMZs) of vascular, neural, and mesenchymal tissues (Myers et al., 1997 
MATERIAL AND METHODS

Animals
Animal handling procedures were approved by the Committee for Animal Research and Welfare of Gifu University. Animal handling procedures were approved by the Committee for Animal Research and Welfare of Gifu University. Animal handling procedures were approved by the Committee for Animal Research and Welfare of Gifu University. ICR mice (Japan SLC Inc.) at 6-8 weeks of age were used with free access to food and water and were maintained on a 12h light/dark cycle.
Collection of embryos
Female mice were superovulated with an intraperitoneal (ip) injection of 5 IU/animal of pregnant mare serum gonadotropin (PMSG) (Sigma Chemical Co, St. Louis, MO) and ip injection of 5 IU/animal of human chorionic gonadotropin (hCG) (Sigma Chemical Co.) at 48-hour intervals. For embryo collection, female mice were mated with males of proven fertility.
Successful mating was determined the next morning by the presence of a vaginal plug which is defined as 0.5 day poscoitum (0.5 dpc). Animals were sacrificed by cervical dislocation. 8-cell stage embryos were collected early in the morning of 2.5 dpc by flushing the oviducts. ICR female mice in estrous cycle were mated with vasectomized males of the same strain to be used as pseudo-pregnant recipient or foster mice for embryo transfer at 0.5 dpc for oviduct transfer or 2.5 dpc for uterine transfer. E14.5 to E18.5 using X-gal whole mount staining and immunohistochemical staining to detect β-galactosidase activity.
Generation of Col19a1nLacZ +/-mice
X-gal staining
For the whole-mount staining, mouse embryos or skin samples were collected from timed pregnant females in cool phosphate buffered saline (PBS). Tail biopsies were harvested for genotyping. Embryos were fixed in 4% paraformaldehyde (PFA, Wako) for 1-3 hours depending on the embryonic stage or 10 min for skin samples. After permeabilization by rinse buffer (0.01% Na-deoxycholate (Wako), 0.02% NP40 (Wako), 2mM Mgcl2 (Wako) in PBS) for 3 times 10 minutes each, embryos were washed with PBS 3 times then stained in Xgal solution (5 mM K-ferricyanide (Wako), 5 mM K-ferrocyanide (Wako), 2 mM MgCl2 in PBS + X-gal (5-bromo-4-chloro-3-indolyl-β-D -galactopyranoside 25 mg/ml Dimethyl formamide (Wako)) at 37 C overnight. The embryos were then post-fixed with 4% PFA. The embryos or skin samples were then cryoprotected with gradual series of sucrose (nacalai tesque) 15%, 30% in PBS at 4 C. The embryos were then embedded in Optimal Cutting Temperature (O.C.T.) medium (Tissue Tek, Sakura, Tokyo, Japan) and 6-8 µm cryosections were cut using a Cryostat (Leica CM1850, Germany) for H&E staining.
Immunohistochemical staining
8~10 μm frozen sections were cut, completely dried, fixed in 4% PFA for 5~10 min, rinsed with 0.05% Tween 20 (Wako)/PBS (PBS-T) 3 times 5 min each. Antigen retrieval was enhanced by incubating in 1% SDS (Sodium Lauryl sulphate (nacalai tesque)) in PBS-T for 5 min followed by washing in PBS-T for 5 min 3 times. The sections were blocked with 5% Skim Milk (Wako) in PBS-T for 1 hr at RT or overnight at 4 to reduce unspecific antibody binding. The sections were then incubated with primary antibodies diluted in blocking solution for 1 hr at RT or overnight at 4 in moist chamber. Primary antibodies used were against β-galactosidase (β-Gal, rabbit, Cappel, 1:1000), SOX2 (SRY (sex determining region Y-box2), rabbit, Invitrogen, 1:100) and Keratin 15 (K15, chicken, Polyclonal, Covance 1:500) followed by rinsing with PBS-T for 5 min three times at least. The tissue sections were then incubated with secondary antibodies (Alexa Fluor 
Imaging
Gross images of whole mount stained embryos were obtained using a digital camera (Canon) or a dissection microscope (Leica MZ 16F) equipped with a camera (AxioCam MRc, Zeiss) driven by Axio Vision 4 software. Light and fluorescent microscopy images were obtained using a Keyence fluorescence microscope driven by BZ-II Viewer and Analyzer software. 
nLacZ_Genotyping_REV: 5ˊ-CTGTTGAGCTGGGTCACTCCAGGGTTCTCC-3ˊ
RESULTS
Generation of a Col19a1LacZ allele
Mouse Col19a1 (Fig.1) . After homologous recombination in ES cells, chimeric mice from correctly targeted ES clones were generated.
Expression pattern of Col19a1 in mouse embryos
To date, the hair development field has been lacking genetic drivers for specific targeting of DP cells, which are thought to interact with epithelial stem cells for morphogenesis to proceed. Here, we generated knock-in reporter mouse lines for specific expression in embryonic DP cells. In a series of wholemount X-Gal stained Col19a1 LacZ embryos, we identified the expression of Col19a1 in the mouse embryonic skin (Fig. 2) . Wide distribution of LacZ expression was detected in the hair follicles of the body, whiskers or vibrissae as well as the skin of leg and tail as shown in Fig.2 . LacZ labeling was also detectable in the subcutaneous muscles and the external genitalia (data not shown).
Expression pattern of Col19a1 during hair follicle morphogenesis
The formation of HF is orchestrated by reciprocal interactions between the epidermis and the underlying mesenchyme.
At E13.5, specialized dermal cells send the first signal to stem cells in the epidermis which rearrange to form hair placodes, which in turn back send a signal to the underlying dermal cells which aggregate to form dermal condensates or DP precursor cells. The DP precursor cells send again a signal to the hair placodes to initiate the proliferation and downgrowth of hair germs and pegs, with the DP cells in the lower edge. Matrix cells that reside at the base of the follicle bulb engulf the DP precursor cells to form the mature DP. This basic morphogenetic consequence of hair follicle formation is repeated in three separate waves giving rise to different hair follicle types.
To determine the stage point of Col19a1
LacZ expression in the dermal compartment of HF, we next analyzed sagittal embryo sections at different embryonic stages (Fig.  3 A-D) . Col19a1 starts to be expressed in the dermal condensates or DP precursor cells of the hair germ stage (Fig. 3B,  arrows) . DP precursor cells continued to express LacZ in the down growing hair peg stage (Fig. 3C , arrow) and in the DP cells of mature HF (Fig. 3D , arrow) but it was not expressed in the dermal condensates of the early hair placode stage (Fig. 3A, arrow) at E14.5.
Col19a1 was expressed in the DP cells of the follicles of the three hair waves of E18.5 back skin (Fig. 4B) . LacZ was sparsely expressed in the reticular layer of the dermis as well (Fig. 4B and 4C , arrow head). LacZ labeling was also detectable in the DP cells of HF of the ventral skin (Fig. 5B, arrow) . Immunofluorescence staining confirmed the expression of Col19a1 by using anti-β-Gal and anti-Sox2 antibodies. β-Gal was expressed in the DP cells of 1 st wave guard HF of back skin (Fig. 4C , arrow) and ventral skin (Fig. 5C, arrow) . Follicles of other waves also showed expression of β-Gal (Fig.  4C ). β-Gal labeling was also detected in the reticular layer of the dermis of back skin (Fig. 4C , arrow head) and ventral skin (Fig.  5C , arrow head). Sox2 as a selectable DP marker was also expressed in the DP cells of HF of back skin (Fig. 4E , arrow) and ventral skin (Fig. 5E, arrow) confirming the expression of Col19a1 in the DP cells. In the whiskers, Col19a1 was expressed in the ring sinus ( Fig. 6C and 6D , arrow) and the neighboring part of inner conical body of whisker follicles. Interestingly, small whisker follicles in the periphery of the whisker showing lacZ labeling in the DP (Fig. 6D , arrow head) in addition to the ring sinus. Absence of lacZ expression in the DP of large whisker follicles up to E18.5 may be attributed to the late expression of Col19a1 in the whisker DP. Moreover, we found that the DP of hair follicles inbetween the whisker rows were also labeled with lacZ ( Fig.  6C , arrow head).
Immunohistochemical staining using anti-β-Gal antibody confirmed the Col19a1 expression in the ring sinus of whisker ( Fig.  6E and 6F, arrows) as well as the DP of small peripheral whisker follicles (Fig. 6F , arrow head). showing lacZ labeling in the ring sinus (arrow). LacZ labeling was also detectable in the DP (arrow head) of small whisker follicles at the periphery of the whisker. (E-H) Immunohistochemical staining.
E, F)
LacZ expression identified by anti-β-galactosid-ase (β-Gal) in the ring sinus (arrow) and in the DP of small peripheral whisker follicles (arrow head). G, H) Negative control for anti-β-Gal. Nuclei were counterstained with DAPI (blue). Scale bars, 50 μm (C-H). C, D) Double staining for leg skin and tail respectively using anti-β-Gal and anti-K15 showing lacZ expression in the basal keratinocyte layer of the epidermis (arrow head). Insert is higher magnification.
Negative control for double stained leg and tail respectively. Nuclei were counterstained with DAPI (blue). Scale bars, 50 μm (A-F).
Dermal-epidermal expression of Col19a1 in the leg and tail skin
Surprisingly, in addition to expression of Col19a1 in the DP cells of HF of leg and tail skin, it was also expressed in the basal keratinocyte layer of epidermis ( Fig. 7A and 7B) of leg and tail respectively. Immunolabeling by double staining using anti-β-Gal and anti-K15 antibodies confirmed the expression of Col19a1 in the leg and tail skin. β-Gal was expressed in the basal keratinocyte layer of the epidermis where the keratinocyte epidermal marker K15 expressed in the leg (Fig. 7C , arrow head) and tail (Fig. 7D, arrow head) . This result confirmed the epidermal expression of Col19a1 in the leg and tail skin.
DISCUSSION
The present study declared that Col19a1 starts to be expressed in the mouse embryonic skin and dermal condensates or DP cells at E14.5 but it was detected in the skin of E16.5 embryos (Sumiyoshi et al., 2001) . The latter authors added that Col19a1 expression during embryogenesis commences at ~E9.5 in the myotome and with a pattern that closely follows the myogenic regulatory factor myf-5. On the other hand, Sumiyoshi et al. (1997) stated that Col19a1 transcripts can be detected as early as 11 days of gestation and in all embryonic tissues, except the liver, of an 18 dpc mouse. In contrast, CD133 as a DP marker starts to be expressed by the DP cells at E16.5 (Ito et al., 2007) while Corin is first detected in the dermal condensate at E15 (Enshell-Seijffers et al., 2008) . Sox2 starts to be detected in the dermal condensates at E14.5 (Driskell et al., 2009) similar to Col19a1 in the present study.
Our results showed that Col19a1 was detected in the dermis as sparse amount in the reticular layer. This result was in contrast with Myers et al. (1997) who stated that the dermis was nonreactive with Col19 antibody. In contrary to some DP markers like Tbx18 which is expressed in the dermal condensates of the earliest placode stage of HF (Grisanti et al., 2013) , the current study showed that Col19a1 LacZ started to be expressed in the dermal condensates of hair germ stage of HF not the hair placode. Therefore, it is tempting to speculate that Col19a1 expression is not mediated by the first wave of hair follicle morphogenesis, but rather than induced by the consequence of the second wave of epidermal and dermal interactions.
In conclusion, the results of the current study are in an agreement with the previous notion that Col19a1 is expressed in the skin and muscles of mouse embryos (Sumiyoshi et al., 1997) . The major new finding reported here is the discovery that Col19a1 was also expressed in the ring sinus and the adjacent part of inner conical body of whiskers and the DP cells of HF starting from hair germ stage as well as in the basal keratinocyte layer of leg and tail epidermis. Meanwhile, Sumiyoshi et al. (2001) Col19-null mice are normal at birth but, ~95% of pups die within the first 3 weeks, presumably caused by their inability to feed due to defects in muscle development in the lower esophageal sphincter demonstrating a role for Col19a1 in the development of skeletal muscle transdifferentiation in the mouse esophagus (Sumiyoshi et al., 2004) . A secondary phenotype has also been observed in hippocampal neurons in mice lacking Col19. Neuronal morphology is normal; however, some subtypes of hippocampal synapses were malformed, demonstrating a role for Col19 in the nervous system (Su et al., 2010) . These mouse studies suggest that Col19a1 may be playing multiple functions during development. Surprisingly, Mammalian ECM including collagens, derived from various tissues and organs, has been used as a biologic scaffold for therapeutic regenerative applications (Badylak, 2005) . More interestingly, DP cells can be reprogrammed into induced pluripotent stem (iPS) cells that can express pluripotency genes and differentiate into cells from all germ layers in vitro and contribute to chimeric mice in vivo, including the germline (Tsai et al., 2010) . This opens avenue for using skin derived iPS cells in regenerative medicine.
Ongoing generation of Col19a1 null mice will ultimately explore the functional role of Col19a1 during HF morphogenesis. From this perspective, it is plausible to expect that future studies will provide additional functional evidence for Col19a1 which might be used as a powerful tool for elucidating the mechanism of HF development. 
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